External Advisor
Frits Peters
Professor Frits Peters is professor emeritus at the Laboratory Medical Oncology, Amsterdam University Medical Center, professor at the Medical University of Gdansk, Poland, and honorary professor at Amity University in Noida, India.
The research of Frits Peters is focused on the development of new cancer treatments, from preclinical research to clinical phase I and II studies. He has been involved in several clinical studies of drug candidates that later gained market approvals for the treatment of cancer, such as gemcitabine, pemetrexed, S-1, TAS-102 and erlotinib. Notably, Frits Peters is recognized as a world leading expert on resistance and the pharmacology of chemotherapy and folate anticancer treatments.
